Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
NewYork–Presbyterian Hospital · Columbia University Irving Medical Center · +22 more institutions
Abstract
The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that among high-risk patients with aortic stenosis, the 1-year survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical replacement. However, longer-term follow-up is necessary to determine whether TAVR has prolonged benefits.
At 25 centers, we randomly assigned 699 high-risk patients with severe aortic stenosis to undergo either surgical aortic-valve replacement or TAVR. All patients were followed for at least 2 years, with assessment of clinical outcomes and echocardiographic evaluation.
Citation impact
- FWCI
- 192.61
- Percentile
- 100%
- References
- 42
Authors
24- SKSusheel KodaliCorresponding
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens
- MWMathew Williams
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens
- CRCraig R. Smith
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens
- LGLars G. Svensson
Cleveland Clinic
- JGJohn G. Webb
University of British Columbia, St. Paul's Hospital
Topics & keywords
- Medicine
- Valve replacement
- Surgery
- Aortic valve replacement
- Aortic valve
- MEDLINE
- Cardiology
- Stenosis